                         SEQUENCE LISTING

<110>  Cara Therapeutics, Inc.
       Schteingart, Claudio D.
       Menzaghi, Frederique
       Jiang, Guangcheng
       Alexander, Roberta V.
       Sueiras-Diaz, Javier
       Spencer, Robert H.
       Chalmers, Derek T.
       Luo, Zhiyong
 
<120>  Synthetic Peptide Amides

<130>  016408-0366471

<140>  To be assigned
<141>  2007-11-12

<150>  60/858,109
<151>  2006-11-10

<150>  60/928,550
<151>  2007-05-10

<160>  8     

<170>  PatentIn version 3.4

<210>  1
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: D-amino acid sequence


<220>
<221>  PEPTIDE
<222>  (1)..(4)
<223>  All D-amino acid sequence

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  Xaa is D-alphamethyl-Lysine bonded to -W-(Y- Z ring)-VeR1R2

<400>  1

Phe Phe Leu Xaa 
1               


<210>  2
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: D-amino acid sequence


<220>
<221>  PEPTIDE
<222>  (1)..(4)
<223>  All D-amino acid sequence.

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  Xaa is D-Lysine bonded to -W-(Y- Z ring)-VeR1R2

<400>  2

Phe Phe Leu Xaa 
1               


<210>  3
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: D-amino acid sequence


<220>
<221>  PEPTIDE
<222>  (1)..(4)
<223>  All D-amino acid sequence

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  Xaa is D-homoarginine bonded to -W-(Y- Z ring)-VeR1R2

<400>  3

Phe Phe Leu Xaa 
1               


<210>  4
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: D-amino acid sequence


<220>
<221>  PEPTIDE
<222>  (1)..(4)
<223>  All D-amino acid sequence

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  Xaa is D-Arginine bonded to -W-(Y- Z ring)-VeR1R2

<400>  4

Phe Phe Leu Xaa 
1               


<210>  5
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: D-amino acid sequence

<220>
<221>  VARIANT
<222>  (1)..(4)
<223>  All D-amino acid sequence.

<220>
<221>  MOD-RES
<222>  (4)..(4)
<223>  Xaa is isopropyl-D-Lysine bonded to -W-(Y- Z ring)-VeR1R2

<400>  5

Phe Phe Leu xaa 
1               


<210>  6
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: D-amino acid sequence

<220>
<221>  VARIANT
<222>  (1)..(4)
<223>  All D-amino acid sequence.

<220>
<221>  MOD-RES
<222>  (4)..(4)
<223>  Xaa is beta-amidino-D-2,3-diaminopropionic acid bonded to -W-(Y- Z 
       ring)-VeR1R2

<400>  6

Phe Phe Leu Xaa 
1               


<210>  7
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: D-amino acid sequence


<220>
<221>  PEPTIDE
<222>  (1)..(4)
<223>  All D-amino acid sequence.

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  Xaa is D-Norarginine bonded to -W-(Y- Z ring)-VeR1R2

<400>  7

Phe Phe Leu Xaa 
1               


<210>  8
<211>  4
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Description of Artificial Sequence: D-amino acid sequence

<220>
<221>  PEPTIDE
<222>  (1)..(4)
<223>  All D-amino acid sequence

<220>
<221>  VARIANT
<222>  (4)..(4)
<223>  Xaa is D-alpha,gamma-diaminobutyric acid bonded to -W-(Y- Z ring)-VeR1R2

<400>  8

Phe Phe Leu Xaa 
1               


